Replimune Group, Inc. (REPL)
NASDAQ·Healthcare·Biotechnology
$2.64
-1.68%
Mkt Cap $199.83M
Analyst Ratings
Buy
2
Hold
3
Sell
2
Price Target (15 analysts)
$13.75
Range $11.00 – $18.00
Implied Upside
+421.8%
Consensus $13.75 vs current $2.64
NASDAQ·Healthcare·Biotechnology
$2.64
-1.68%
Mkt Cap $199.83M
Buy
2
Hold
3
Sell
2
Price Target (15 analysts)
$13.75
Range $11.00 – $18.00
+421.8%
Consensus $13.75 vs current $2.64